AFP and neoplasm: Elevated levels of tumor markers, including AFP or PIVKA‐II, were reported in six patients before the diagnosis of small bowel metastasis and included three (21%) patients with no subjective symptoms, apart from elevated tumor markers, during regular follow‐up.